Ankylosing Spondylitis Central

Researchers found significantly lower treatment rates for women with ankylosing spondyloarthritis in multiple studies analyzing clinical trials in axial spondylarthritis, resulting in poor outcomes and response to therapies once started.

Accurately diagnosing ankylosing spondylitis is a challenge for physicians, who must rely on a combination of symptoms and inflammation in place of a definitive blood marker.

The time a person with ankylosing spondylitis spends undiagnosed can negatively impact quality of life.